Charles Schwab’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2M | Buy |
1,436,112
+109,341
| +8% | +$2.37M | 0.01% | 1410 |
|
|
2025
Q1 | $32.2M | Buy |
1,326,771
+79,846
| +6% | +$1.94M | 0.01% | 1358 |
|
|
2024
Q4 | $26M | Buy |
1,246,925
+79,182
| +7% | +$1.65M | ﹤0.01% | 1557 |
|
|
2024
Q3 | $23.2M | Buy |
1,167,743
+50,804
| +5% | +$1.01M | ﹤0.01% | 1620 |
|
|
2024
Q2 | $17.3M | Buy |
1,116,939
+41,380
| +4% | +$641K | ﹤0.01% | 1767 |
|
|
2024
Q1 | $17.1M | Buy |
1,075,559
+119,226
| +12% | +$1.9M | ﹤0.01% | 1701 |
|
|
2023
Q4 | $16.1M | Buy |
956,333
+35,006
| +4% | +$588K | ﹤0.01% | 1719 |
|
|
2023
Q3 | $10.8M | Buy |
921,327
+58,018
| +7% | +$678K | ﹤0.01% | 1874 |
|
|
2023
Q2 | $11.6M | Sell |
863,309
-355,866
| -29% | -$4.78M | ﹤0.01% | 1843 |
|
|
2023
Q1 | $20.2M | Sell |
1,219,175
-28,239
| -2% | -$468K | 0.01% | 1464 |
|
|
2022
Q4 | $23.2M | Buy |
1,247,414
+31,503
| +3% | +$586K | 0.01% | 1332 |
|
|
2022
Q3 | $15.6M | Buy |
1,215,911
+34,504
| +3% | +$443K | 0.01% | 1555 |
|
|
2022
Q2 | $8.28M | Buy |
1,181,407
+350,042
| +42% | +$2.45M | ﹤0.01% | 1934 |
|
|
2022
Q1 | $6.89M | Buy |
831,365
+11,569
| +1% | +$95.9K | ﹤0.01% | 2127 |
|
|
2021
Q4 | $5.55M | Buy |
819,796
+18,552
| +2% | +$126K | ﹤0.01% | 2301 |
|
|
2021
Q3 | $4.25M | Buy |
801,244
+2,005
| +0.3% | +$10.6K | ﹤0.01% | 2452 |
|
|
2021
Q2 | $4.6M | Sell |
799,239
-170,468
| -18% | -$980K | ﹤0.01% | 2392 |
|
|
2021
Q1 | $4.47M | Sell |
969,707
-25,033
| -3% | -$115K | ﹤0.01% | 2351 |
|
|
2020
Q4 | $3.32M | Buy |
994,740
+94,442
| +10% | +$315K | ﹤0.01% | 2415 |
|
|
2020
Q3 | $2.67M | Sell |
900,298
-5,295
| -0.6% | -$15.7K | ﹤0.01% | 2386 |
|
|
2020
Q2 | $4.18M | Buy |
905,593
+40,734
| +5% | +$188K | ﹤0.01% | 2105 |
|
|
2020
Q1 | $3.33M | Buy |
864,859
+55,039
| +7% | +$212K | ﹤0.01% | 2043 |
|
|
2019
Q4 | $3.04M | Buy |
809,820
+238,842
| +42% | +$896K | ﹤0.01% | 2272 |
|
|
2019
Q3 | $3.03M | Buy |
570,978
+344,790
| +152% | +$1.83M | ﹤0.01% | 2223 |
|
|
2019
Q2 | $869K | Hold |
226,188
| – | – | ﹤0.01% | 2618 |
|
|
2019
Q1 | $1.15M | Buy |
226,188
+17,784
| +9% | +$90.7K | ﹤0.01% | 2517 |
|
|
2018
Q4 | $401K | Hold |
208,404
| – | – | ﹤0.01% | 2841 |
|
|
2018
Q3 | $788K | Hold |
208,404
| – | – | ﹤0.01% | 2697 |
|
|
2018
Q2 | $651K | Buy |
208,404
+23,500
| +13% | +$73.4K | ﹤0.01% | 2708 |
|
|
2018
Q1 | $442K | Buy |
184,904
+36,200
| +24% | +$86.5K | ﹤0.01% | 2766 |
|
|
2017
Q4 | $582K | Buy |
148,704
+28,204
| +23% | +$110K | ﹤0.01% | 2688 |
|
|
2017
Q3 | $304K | Hold |
120,500
| – | – | ﹤0.01% | 2864 |
|
|
2017
Q2 | $333K | Buy |
+120,500
| New | +$333K | ﹤0.01% | 2824 |
|
|
2016
Q2 | – | Sell |
-107,345
| Closed | -$126K | – | 3114 |
|
|
2016
Q1 | $126K | Hold |
107,345
| – | – | ﹤0.01% | 2963 |
|
|
2015
Q4 | $263K | Hold |
107,345
| – | – | ﹤0.01% | 2901 |
|
|
2015
Q3 | $323K | Hold |
107,345
| – | – | ﹤0.01% | 2797 |
|
|
2015
Q2 | $444K | Buy |
+107,345
| New | +$444K | ﹤0.01% | 2714 |
|